Join the Morphine group to help and get support from people like you.
Morphine News
'Drug Take Back Day' is Saturday: Check for Leftover Opioids in Your Home
FRIDAY, April 26, 2024 – Each year, thousands of Americans head home after a surgery clutching prescription opioids to help ease post-surgical pain. Trouble is, most won't use all those pills, and...
Prescription Opioids Linked to Increased Risk for Serious Fall Events
TUESDAY, Feb. 20, 2024 – For adults of all ages, especially those aged 85 years or older, prescription opioids are associated with an increased risk for serious fall events, according to a study...
Mom's Opioid Use in Pregnancy Raises Child's Asthma, Eczema Risk
THURSDAY, Jan. 18, 2024 – Fetal exposure to opioids may change a baby's immune system, triggering a rise in risks for eczema and asthma through early childhood, new research shows. Children born to...
Personalized Protocol Cuts Opioid Prescribing After C-Section
TUESDAY, Jan. 2, 2024 – A personalized protocol for opioid prescriptions after cesarean delivery reduces the median morphine milligram equivalents prescribed at discharge, according to a study...
Teen Surgery-Linked Opioid Prescription Rates Stable From 2015 to 2020
TUESDAY, Oct. 10, 2023 – For U.S. adolescents, there was a decrease in opioid prescription rates from 2015 to 2020 for nonsurgical indications, but opioid prescription rates associated with surgery...
Most Patients Seen in Emergency Department for Pain Consume Few Opioids After Discharge
THURSDAY, Sept. 21, 2023 – Opioid prescriptions following emergency department discharge should be adapted to specific acute pain conditions, according to a study presented at the annual European...
Opioid-Free Discharge Feasible After Pancreatectomy
THURSDAY, Sept. 7, 2023 – Opioid-free discharge is feasible after pancreatic surgery, according to a study published online Sept. 6 in JAMA Surgery. Artem Boyev, D.O., from The University of Texas...
1 in 10 ICU Patients With Heart Issues Has Illicit Drugs in Their System
FRIDAY, Aug. 18, 2023 – More than 1 out of every 10 patients who land in an ICU with a potentially deadly heart emergency test positive for recreational drug use, a new French study reports. About...
Prevalence of Recreational Drug Use 11 Percent in Cardiac ICUs
FRIDAY, Aug. 18, 2023 – For patients hospitalized in intensive cardiac care units (ICCUs), the prevalence of recreational drug use is 11 percent, according to a study published online Aug. 15 in...
Most People Initiating Opioid Rx Have Very Low Use Trajectory
MONDAY, Aug. 14, 2023 – Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published...
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
FDA Medwatch Alert: Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up
June 28, 2022 – Burbank, California, Bryant Ranch Prepack Inc. is voluntarily recalling one lot of Morphine Sulfate 30 mg Extended-Release tablets (Comprised of 10 bottles), and one lot of Morphine S...
FDA Medwatch Alert: Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination
ISSUE: SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. There is a potential for the products to contain microbial co...
FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation
OSAKA, Japan and FLORHAM PARK, N.J. and STAMFORD, Conn., March 23, 2017 /PRNewswire/ – Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved...
FDA Approves Arymo ER (morphine sulfate) Abuse-Deterrent Formulation for the Treatment of Chronic Pain
WAYNE, Penn., Jan. 9, 2017 /PRNewswire/ – Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing...
Ask a question
To post your own question to this support group, sign in or create an account.